Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Giotto Biotech is an Italian private biotech and life science services company spun out of the Magnetic Resonance Center (CERM) at the University of Florence. The company provides recombinant proteins and peptides, antibody production, custom organic synthesis, NMR standards, NMR-based metabolomics, and access to NMR instrumentation for academic and industrial research users. Giotto Biotech has particular expertise in producing E. coli-expressed proteins, including isotopically labeled proteins for NMR applications, and in supplying reference compounds and analytical standards. Its business appears to be primarily tools-and-services oriented rather than a therapeutics developer with a disclosed clinical drug pipeline. The company also collaborates with CERM and markets specialized products and custom research support to the biotech, biopharma, and research communities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Giotto Biotech.